CHARLES RIVER LABORATORIES INTERNATIONAL, INC. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax of $0 for the 12-month period ending 2013-12-28, per its 10-K filed 2014-02-25.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax · last filed 2014-02-25
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2013-12-28 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2013-09-28 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2013-06-29 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2013-03-30 was $0.00, a 100.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2012 was $209.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2011 was -$325.00K, a 138.10% decline from fiscal 2010.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2010 was $853.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 3 month as first filed | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 6 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 6 month as first filed | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 9 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 9 month as first filed | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 12 month |
|---|---|---|---|---|---|---|---|
| 2013-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $0.00 derived: sum of 2 quarters · filed 2014-02-25 | $0.00 derived: sum of 3 quarters · filed 2014-02-25 | $0.00 10-K · filed 2014-02-25 | |||
| 2013-09-28 | $0.00 10-Q · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $0.00 10-Q · filed 2013-10-30 | $0.00 derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2013-06-29 | $0.00 10-Q · filed 2013-07-31 | $0.00 10-Q · filed 2013-07-31 | $0.00 derived: sum of 3 quarters · filed 2014-02-25 | $0.00 derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2013-03-30 | $0.00 10-Q · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2014-02-25 | $0.00 derived: sum of 3 quarters · filed 2014-02-25 | $0.00 derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $0.00 derived: sum of 2 quarters · filed 2014-02-25 | $0.00 derived: sum of 3 quarters · filed 2014-02-25 | $209.00K 10-K · filed 2014-02-25 | |||
| 2012-09-29 | $0.00 10-Q · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $209.00K 10-Q · filed 2013-10-30 | -$209.00K 10-Q · filed 2012-11-01 | -$421.00K derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | $0.00 10-Q · filed 2013-07-31 | $209.00K 10-Q · filed 2013-07-31 | -$209.00K 10-Q · filed 2012-08-07 | -$421.00K derived: sum of 3 quarters · filed 2014-02-25 | -$253.00K derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $209.00K 10-Q · filed 2013-05-08 | -$209.00K 10-Q · filed 2012-05-04 | -$421.00K derived: sum of 2 quarters · filed 2014-02-25 | -$253.00K derived: sum of 3 quarters · filed 2014-02-25 | -$201.00K derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2011-12-31 | -$630.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$462.00K derived: sum of 2 quarters · filed 2014-02-25 | -$410.00K derived: sum of 3 quarters · filed 2014-02-25 | -$325.00K 10-K · filed 2014-02-25 | |||
| 2011-09-24 | $168.00K 10-Q · filed 2012-11-01 | $220.00K derived: sum of 2 quarters · filed 2012-11-01 | $305.00K 10-Q · filed 2012-11-01 | ||||
| 2011-06-25 | $52.00K 10-Q · filed 2012-08-07 | $137.00K 10-Q · filed 2012-08-07 | |||||
| 2011-03-26 | $85.00K 10-Q · filed 2012-05-04 | ||||||
| 2010-12-25 | $853.00K 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |